Jesse Feiko Veenis1, MD; Nicolas M. Van Mieghem1, MD, PhD, FESC; Kadir Caliskan1, MD, PhD, FESC; Olivier C. Manintveld1, MD, PhD; Jasper J. Brugts1, MD, PhD, FESC, MSc
1. Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
Figure 1. Pre- and post-MitraClip daily PAP readings.
In chronic heart failure (HF) patients, functional mitral valve regurgitation (FMR) is a common finding and is associated with worse outcome. The position of the MitraClip™ (Abbott Vascular, Santa Clara, CA, USA) as a therapeutic option is still debated after the publication of the MITRA-FR and COAPT trials, showing conflicting results.
A 51-year-old male, with a history of severely dilated, non-ischaemic cardiomyopathy, severe FMR, actively on the heart transplant (HTx) waiting list, remotely monitored with the CardioMEMS™ sensor (Abbott Vascular), developed persistent elevated pulmonary artery pressures (PAPs) (...